Enzyme could help prevent neurodegenerative diseases – study
Scientists have identified a missing link that can help protect [...]
Amnesia caused by head injury could be reversed, finds study
A new study designed to shed light on amnesia and [...]
Your NR Headlines: Wednesday 7th February
Welcome to your daily round-up of everything happening in the world of neurorehabilitation.
Subscribe to unlock the latest research, policy developments and company updates in the field of neurorehab.
New £5m research network to open up MND trials access
The MND Association is investing £5m into building a network [...]
Children with mTBIs at increased risk of affective and behavioural disorders – study
Children who have sustained a mild traumatic brain injury (mTBI) [...]
APIL warns increasing court fees may price out injured claimants
Personal injury lawyers have warned against plans put forward by [...]
Brain pathway could shed new light on neurodegenerative diseases
Researchers have established a brain pathway linking motivation, addiction and [...]
Study reveals significant racial and ethnic disparities in dementia care
A new study has revealed significant disparities in healthcare quality [...]
Injection guidance and improved rehab outcomes – Ipsen study
Biopharma firm Ipsen has identified links between injection guidance techniques and improved rehab outcomes in people with lower-limb spasticity.
Ipsen’s AboLiSh study evaluated the use and effectiveness of Dysport®(abobotulinumtoxinA) in people living with lower-limb spasticity.
It found that injection guidance techniques significantly help to improve outcomes and goal attainment in patients.
